Venture capital

China-US biotech firm closes $80m Series B funding

Sino-US trade tensions have not discouraged Korean investors from China's booming biotech industry as the cancer immunology specialist completes its Series B funding.
June 10, 2019

Shanghai and Boston-based oncology therapy provider Oncologie has raised $80 million Series B funding from Chinese and Korean investors.

¬ Haymarket Media Limited. All rights reserved.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.

Share our publication on social media
Share our publication on social media